Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Pro-neurogenic Effects of Cannabidiol and Its Potential Therapeutic Implications in Psychiatric Disorders
Miguel Á. Luján, Olga Valverde
Frontiers in Behavioral Neuroscience (2020) Vol. 14
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59
Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice
Nicole M. Wanner, Mathia Colwell, Chelsea Drown, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression
Inés Gallego‐Landin, Alba García-Baos, Adriana Castro‐Zavala, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 50
Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries
Mackenzie M. Aychman, David L. Goldman, Joshua S. Kaplan
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 16
Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review
Justin Matheson, Zoe Bourgault, Bernard Le Foll
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1462-1462
Open Access | Times Cited: 21
Cannabidiol repairs behavioral and brain disturbances in a model of fetal alcohol spectrum disorder
Ani Gasparyan, Daniela Navarro, Francisco Navarrete, et al.
Pharmacological Research (2023) Vol. 188, pp. 106655-106655
Open Access | Times Cited: 10
Cannabidiol decreases motivation for cocaine in a behavioral economics paradigm but does not prevent incubation of craving in mice
Laia Alegre-Zurano, Paula Berbegal-Sáez, Miguel Á. Luján, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112708-112708
Open Access | Times Cited: 14
Prophylactic Administration of Cannabidiol Reduces Microglial Inflammatory Response to Kainate-Induced Seizures and Neurogenesis
Tanya R. Victor, Zachary Hage, Stella E. Tsirka
Neuroscience (2022) Vol. 500, pp. 1-11
Open Access | Times Cited: 14
In Vitro Studies on Therapeutic Effects of Cannabidiol in Neural Cells: Neurons, Glia, and Neural Stem Cells
Kim Jungnam, Hyunwoo Choi, Eunhye Kang, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 6077-6077
Open Access | Times Cited: 19
Early-life stress induces emotional and molecular alterations in female mice that are partially reversed by cannabidiol
Ana Martín‐Sánchez, Héctor González‐Pardo, Laia Alegre-Zurano, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 115, pp. 110508-110508
Closed Access | Times Cited: 19
Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments
Hugo Bayer, Cristina Aparecida Jark Stern, Fernanda Troyner, et al.
Neuropharmacology (2021) Vol. 205, pp. 108913-108913
Closed Access | Times Cited: 18
Regulation of DNA Methylation by Cannabidiol and Its Implications for Psychiatry: New Insights from In Vivo and In Silico Models
Luana B. Domingos, Nicole Rodrigues da Silva, Adriano José Maia Chaves Filho, et al.
Genes (2022) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 13
Unveiling the Potential of Phytocannabinoids: Exploring Marijuana’s Lesser-Known Constituents for Neurological Disorders
Balapal S. Basavarajappa, Shivakumar Subbanna
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1296-1296
Open Access | Times Cited: 2
Evidence from Human Studies for Utilising Cannabinoids for the Treatment of Substance-Use Disorders: A Scoping Review with a Systematic Approach
Kayvan Ali Gharbi, Yvonne Bonomo, Christine Mary Hallinan
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 4087-4087
Open Access | Times Cited: 5
Evaluation of the efficacy of a full-spectrum medicinal cannabis plant extract with less than 0.3% Delta9-tetrahydrocannabinol in in vitro models of inflammation and excitotoxicity
Emily Ross-Munro, Esra Isikgel, Bobbi Fleiss
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Enhanced oral bioavailability of cannabidiol by flexible zein nanoparticles: in vitro and pharmacokinetic studies
YingLan Nie, Yan Kong, Juan Peng, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 1
FDA-approved cannabidiol [Epidiolex®] alleviates Gulf War Illness-linked cognitive and mood dysfunction, hyperalgesia, neuroinflammatory signaling, and declined neurogenesis
Maheedhar Kodali, Leelavathi N. Madhu, Venkata Sai Vashishta Kolla, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Novel Pharmacotherapies for L-DOPA-Induced Dyskinesia
Yousef Tizabi, Bruk Getachew, Robert Copeland, et al.
Springer eBooks (2021), pp. 1-19
Closed Access | Times Cited: 5
Novel Pharmacotherapies for L-DOPA-Induced Dyskinesia
Yousef Tizabi, Bruk Getachew, Robert Copeland, et al.
Springer eBooks (2022), pp. 1637-1655
Closed Access | Times Cited: 3
Cannabidiol Modulates Neuroinflammatory Markers in a PTSD Model Conducted on Female Rats
Anna Portugalov, Gaia Peled, S Zorin, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1384-1384
Open Access
Evaluation of the Efficacy of a Full-Spectrum Low-THC Cannabis Plant Extract Using In Vitro Models of Inflammation and Excitotoxicity
Emily Ross-Munro, Esra Isikgel, Bobbi Fleiss
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1434-1434
Open Access
Hesperidin produces antidepressant effects by activating AMPA receptor: enhancing synaptic proteins to promote hippocampal neuronal activities
Bo Pang, Ting Cao
Behavioural Pharmacology (2024)
Closed Access
Cannabinoid-based Pharmacology for the Management of Substance Use Disorders
Miguel Á. Luján, Younghoon Kim, Linlin Zhang, et al.
Current topics in behavioral neurosciences (2024)
Closed Access
Neurociência do canabidiol – aspectos neurocognitivos, terapêuticos e comportamentais
Fernando Campos Barbosa, Rodrigo Martins Tadine, Janaína Drawanz Pereira Rezende, et al.
OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA (2023) Vol. 21, Iss. 8, pp. 8891-8914
Open Access
Molecular and cellular principles of endocannabinoid signaling and their sensitivity to cannabis in the developing brain
Erik Keimpema, Tibor Harkany
Elsevier eBooks (2022), pp. 149-170
Closed Access
Page 1 - Next Page

Scroll to top